Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Phase II study of sorafenib in children with recurrent or progressive low-grade astrocytomas.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Phase II study of sorafenib in children with recurrent or progressive low-grade astrocytomas.
Phase II study of sorafenib in children with recurrent or progressive low-grade astrocytomas. Neuro Oncol. 2014 Oct; 16(10):1408-16.
View in:
PubMed
subject areas
Adolescent
Animals
Antineoplastic Agents
Astrocytoma
Brain Neoplasms
Child, Preschool
Female
Humans
Kaplan-Meier Estimate
Magnetic Resonance Imaging
Male
MAP Kinase Signaling System
Mice
Niacinamide
NIH 3T3 Cells
Phenylurea Compounds
Protein Kinase Inhibitors
Treatment Outcome
authors with profiles
Kenneth S. Cohen